| 1 |
Wang J, Qin T, Sun J, Li S, Cao L, Lu X. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease. Front Physiol 2022;13:1046497. [PMID: 36589424 DOI: 10.3389/fphys.2022.1046497] [Reference Citation Analysis]
|
| 2 |
Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney JAC, Bamford L, Wooten D, Karris MY, Mathews WC, Kim HN, Keruly J, Burkholder G, Napravnik S, Mayer KH, Jacobson J, Saag M, Moore RD, Eron JJ, Willig AL, Christopoulos KA, Martin J, Hunt PW, Crane HM, Kitahata MM, Cachay ER; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS). Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States. AIDS 2022;36:1095-103. [PMID: 35796731 DOI: 10.1097/QAD.0000000000003223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Zuluaga P, Teniente-Serra A, Fuster D, Quirant-Sánchez B, Hernandez-Rubio A, Martínez-Cáceres E, Muga R. Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. J Clin Med 2022;11:305. [PMID: 35054000 DOI: 10.3390/jcm11020305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Bender Ignacio R, Shapiro A, Nance R, Whitney B, Delaney J, Bamford L, Wooten D, Karris M, Mathews W, Kim H, Van Rompaey S, Keruly J, Burkholder G, Napravnik S, Mayer K, Jacobson J, Saag M, Moore R, Eron J, Willig A, Christopoulos K, Martin J, Hunt P, Crane H, Kitahata M, Cachay E, for the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS). Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.. [DOI: 10.1101/2021.12.07.21267296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM; CFAR Network of Integrated Clinical Systems. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. medRxiv 2021:2021. [PMID: 34704092 DOI: 10.1101/2021.10.15.21265063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Ieda S, Miyamoto T, Hosomi K, Takegami M, Kawabata A. Identification of Remaining Life Expectancy Less Than Two Weeks by C-Reactive Protein/Albumin Ratio, Prognostic Nutritional Index, Fibrosis-4 Index, and Albumin-Bilirubin Score in Terminal Cancer Patients. J Palliat Med 2021. [PMID: 34612718 DOI: 10.1089/jpm.2021.0243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Zhang X, Guan L, Tian H, Zeng Z, Chen J, Huang D, Sun J, Guo J, Cui H, Li Y. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Front Oncol 2021;11:686962. [PMID: 34568017 DOI: 10.3389/fonc.2021.686962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Yongpisarn T, Thimphitthaya C, Laoveeravat P, Wongjarupong N, Chaiteerakij R. Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis. World J Hepatol 2021; 13(8): 949-968 [PMID: 34552701 DOI: 10.4254/wjh.v13.i8.949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Fuster D, Garcia-Calvo X, Farré O, Zuluaga P, Bolao F, Leis A, Hernández-Rubio A, Rivas I, Muga R. Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder. J Clin Med 2021;10:3496. [PMID: 34441792 DOI: 10.3390/jcm10163496] [Reference Citation Analysis]
|
| 11 |
Rodart IF, Pares MM, Mendes A, Accardo CM, Martins JRM, Silva CB, Carvalho FO, Barreto JA, Reis MG, Tersariol ILS, Nader HB. Diagnostic Accuracy of Serum Hyaluronan for Detecting HCV Infection and Liver Fibrosis in Asymptomatic Blood Donors. Molecules 2021;26:3892. [PMID: 34202190 DOI: 10.3390/molecules26133892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol 2021; 27(23): 3223-3237 [PMID: 34163107 DOI: 10.3748/wjg.v27.i23.3223] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Jayaswal ANA, Levick C, Selvaraj EA, Dennis A, Booth JC, Collier J, Cobbold J, Tunnicliffe EM, Kelly M, Barnes E, Neubauer S, Banerjee R, Pavlides M. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. Liver Int 2020;40:3071-82. [PMID: 32730664 DOI: 10.1111/liv.14625] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 14 |
Zarski JP, David-Tchouda S, Trocme C, Margier J, Vilotitch A, Hilleret MN, Cagnot C, Boursier V, Ziol M, Sutton A, Layese R, Audureau E, Roudot-Thoraval F, Nahon P. Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clin Res Hepatol Gastroenterol 2020;44:524-31. [PMID: 31839535 DOI: 10.1016/j.clinre.2019.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Shahramian I, Khalili M, Sargazi A, Dechal A, Bazi M, Jahantigh M, Delaramnasab M, Bazi A. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic Disorders. Gene Cell Tissue 2020;7. [DOI: 10.5812/gct.101443] [Reference Citation Analysis]
|
| 16 |
Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Crane HM, Nance RM, Heckbert SR, Ritchings C, Rosenblatt L, Budoff M, Wood BR, Tirschwell DL, Kim HN, Mathews WC, Geng E, Moore RD, Hunt PW, Eron JJ, Burkholder GA, Drozd DR, Chow FC, Becker KJ, Zunt JR, Ho EL, Kalani R, Huffer A, Whitney BM, Saag MS, Kitahata MM, Delaney JAC. Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States. J Acquir Immune Defic Syndr 2019;81:e141-7. [PMID: 31135582 DOI: 10.1097/QAI.0000000000002071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Koļesova O, Madelāne M, Ekšteina I, Koļesovs A, Krūmiņa A, Vīksna L. The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:94-99. [DOI: 10.2478/prolas-2020-0015] [Reference Citation Analysis]
|
| 19 |
Barré T, Protopopescu C, Bani-Sadr F, Piroth L, Rojas Rojas T, Salmon-Ceron D, Wittkop L, Esterle L, Sogni P, Lacombe K, Chas J, Zaegel O, Chaix ML, Miailhes P, Serfaty L, Marcellin F, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study). Hepatology 2020;71:1182-97. [PMID: 31466125 DOI: 10.1002/hep.30914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Chen Q, Li Q, Li D, Chen X, Liu Z, Hu G, Wang J, Ling W. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. Atherosclerosis 2020;299:45-52. [PMID: 32240838 DOI: 10.1016/j.atherosclerosis.2020.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 21 |
Patel PJ, Connoley D, Rhodes F, Srivastava A, Rosenberg W. A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease. Ann Clin Biochem 2020;57:36-43. [PMID: 31529981 DOI: 10.1177/0004563219879962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 22 |
Babiker A, Hassan M, Muhammed S, Taylor G, Poonia B, Shah A, Bagchi S. Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review. Clin Cardiol 2020;43:222-34. [PMID: 31785111 DOI: 10.1002/clc.23299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, Gervais A, Naqvi A, Rosenthal E, Garipuy D, Barange K, Esterle L, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol 2019;31:1387-96. [PMID: 31033848 DOI: 10.1097/MEG.0000000000001408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Fuster D, Garcia-calvo X, Zuluaga P, Rivas I, Sanvisens A, Tor J, Muga R. Liver Ultrasound Abnormalities in Alcohol Use Disorder. Essentials of Abdominal Ultrasound 2019. [DOI: 10.5772/intechopen.85941] [Reference Citation Analysis]
|
| 25 |
Li X, Xu H, Gao P. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. Med Sci Monit 2019;25:7243-50. [PMID: 31558693 DOI: 10.12659/MSM.918784] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 26 |
Cai J, Osikowicz M, Sebastiani G. Clinical significance of elevated liver transaminases in HIV-infected patients. AIDS 2019;33:1267-82. [PMID: 31008799 DOI: 10.1097/QAD.0000000000002233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 27 |
Na SK, Lee SJ, Cho YK, Kim YN, Choi EK, Song BC. Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy. J Interferon Cytokine Res. 2019;39:703-710. [PMID: 31216229 DOI: 10.1089/jir.2019.0049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 28 |
Yoshino K, Taura K, Okuda Y, Ikeno Y, Uemoto Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Seo S, Kaido T, Okajima H, Imai T, Tanaka S, Uemoto S. Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation. Hepatol Res 2019;49:394-403. [PMID: 30471140 DOI: 10.1111/hepr.13289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 29 |
Mushtaq S, Ghani E, Azam K, Hussain T. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography. Eur J Gastroenterol Hepatol 2019;31:357-62. [PMID: 30431458 DOI: 10.1097/MEG.0000000000001291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 30 |
Hansen JF, Christiansen KM, Staugaard B, Moessner BK, Lillevang S, Krag A, Christensen PB. Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C. PLoS One 2019;14:e0212036. [PMID: 30742668 DOI: 10.1371/journal.pone.0212036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 31 |
Knop V, Hofmann WP, Buggisch P, Klinker H, Mauss S, Günther R, Hinrichsen H, Hüppe D, Pfeiffer-Vornkahl H, Simon KG, Berg T, Manns MP, Friedrich-Rust M; German Hepatitis C-Registry. Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment. J Viral Hepat 2019;26:224-30. [PMID: 30315694 DOI: 10.1111/jvh.13021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Hsieh YC, Lee KC, Wang YW, Yang YY, Hou MC, Huo TI, Lin HC. Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score. PLoS One 2018;13:e0208903. [PMID: 30540824 DOI: 10.1371/journal.pone.0208903] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 33 |
Price JC, Seaberg EC, Stosor V, Witt MD, Lellock CD, Thio CL. Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men. AIDS 2018;32:2636-8. [PMID: 30096072 DOI: 10.1097/QAD.0000000000001977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 34 |
Fuster D, Garcia-Calvo X, Zuluaga P, Rivas I, Sanvisens A, Tor J, Muga R. Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug Alcohol Depend 2018;190:195-9. [PMID: 30048873 DOI: 10.1016/j.drugalcdep.2018.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 35 |
Plevris N, Sinha R, Hay AW, McDonald N, Plevris JN, Hayes PC. Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease. Aliment Pharmacol Ther 2018;48:423-30. [PMID: 29971829 DOI: 10.1111/apt.14897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Saracino A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, Nozza S, Di Biagio A, Cassola G, Bruno G, Capobianchi M, Puoti M, Monno L, d'Arminio Monforte A; ICONA Foundation Study. HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients. PLoS One 2018;13:e0190302. [PMID: 29324755 DOI: 10.1371/journal.pone.0190302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 37 |
Sherman KE, Sterling RK. HIV and the Liver. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00037-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 38 |
Pembroke T, Sebastiani G. Non-invasive Serum Markers of Fibrosis. Diagnostic Methods for Cirrhosis and Portal Hypertension 2018. [DOI: 10.1007/978-3-319-72628-1_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 39 |
Xiao L, Wang W, Xian J, Zhang W, Li Y, Yang X, Lu L. Annual Change in FIB-4, but not in APRI, was a Strong Predictor for Liver Disease Progression in Chinese Patients with Chronic Hepatitis C. Hepat Mon 2017;18. [DOI: 10.5812/hepatmon.57250] [Reference Citation Analysis]
|
| 40 |
Kim HN, Crane HM, Rodriguez CV, Van Rompaey S, Mayer KH, Christopoulos K, Napravnik S, Chander G, Hutton H, McCaul ME, Cachay ER, Mugavero MJ, Moore R, Geng E, Eron JJ, Saag MS, Merrill JO, Kitahata MM. The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals. AIDS Behav 2017;21:1878-84. [PMID: 28035496 DOI: 10.1007/s10461-016-1665-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Thandassery RB, Kaabi SA, Soofi ME, Tharian B, Singh R. Noninvasive serum models to predict significant liver related events in chronic hepatitis C. Hepatol Int 2017;11:401-8. [DOI: 10.1007/s12072-017-9800-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 42 |
Bertrais S, Boursier J, Ducancelle A, Oberti F, Fouchard-Hubert I, Moal V, Calès P. Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests. J Gastroenterol Hepatol 2017;32:1240-9. [PMID: 27897323 DOI: 10.1111/jgh.13668] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017;5:79-89. [PMID: 28533906 DOI: 10.1093/gastro/gox012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 44 |
Mobarak L, Omran D, Nabeel MM, Zakaria Z. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease: Fibrosis Markers for Hepatocellular Carcinoma Prediction. J Med Virol 2017;89:1062-8. [DOI: 10.1002/jmv.24720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 45 |
Kim JH, Kim JW, Seo JW, Choe WH, Kwon SY. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. J Clin Gastroenterol 2016;50:882-8. [PMID: 27322532 DOI: 10.1097/MCG.0000000000000574] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 46 |
Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma. Dig Liver Dis 2016;48:1220-6. [PMID: 27599803 DOI: 10.1016/j.dld.2016.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 47 |
Cepeda JA, Solomon SS, Srikrishnan AK, Nandagopal P, Balakrishnan P, Kumar MS, Thomas DL, Sulkowski MS, Mehta SH. Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India. Open Forum Infect Dis 2016;3:ofw156. [PMID: 27704012 DOI: 10.1093/ofid/ofw156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 48 |
Mao W, Sun Q, Fan J, Lin S, Ye B. AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis. Medicine (Baltimore) 2016;95:e2946. [PMID: 26945406 DOI: 10.1097/MD.0000000000002946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 49 |
Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) 2016;95:e2877. [PMID: 26937922 DOI: 10.1097/MD.0000000000002877] [Cited by in Crossref: 230] [Cited by in F6Publishing: 249] [Article Influence: 32.9] [Reference Citation Analysis]
|
| 50 |
Kooij KW, Wit FW, van Zoest RA, Schouten J, Kootstra NA, van Vugt M, Prins M, Reiss P, van der Valk M; AGEhIV Cohort Study Group. Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine. AIDS 2016;30:1771-80. [PMID: 27088320 DOI: 10.1097/QAD.0000000000001119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 51 |
Nishio T, Taura K, Koyama Y, Tanabe K, Yamamoto G, Okuda Y, Ikeno Y, Seo S, Yasuchika K, Hatano E, Okajima H, Kaido T, Tanaka S, Uemoto S. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma. Surgery 2016;159:399-408. [DOI: 10.1016/j.surg.2015.06.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 52 |
Baranoski AS, Cotton D, Heeren T, Nunes D, Kubiak RW, Horsburgh CR Jr. Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men. Open Forum Infect Dis 2016;3:ofv214. [PMID: 26955643 DOI: 10.1093/ofid/ofv214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Asrani SK. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis. Clin Gastroenterol Hepatol 2015;13:2190-204. [PMID: 26226095 DOI: 10.1016/j.cgh.2015.07.030] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 54 |
Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015;45:1083-90. [PMID: 25565570 DOI: 10.1111/hepr.12473] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 55 |
Wang C, Liu C, Lin C, Wang P, Tseng T, Lin HH, Kao J. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association 2015;114:923-8. [DOI: 10.1016/j.jfma.2015.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 56 |
Tamaki N, Kurosaki M, Kuno A, Korenaga M, Togayachi A, Gotoh M, Nakakuki N, Takada H, Matsuda S, Hattori N, Yasui Y, Suzuki S, Hosokawa T, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Mizokami M, Narimatsu H, Izumi N. Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients. Hepatol Res 2015;45:E82-8. [PMID: 25559682 DOI: 10.1111/hepr.12466] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 57 |
Neuman MG, Cohen LB, Nanau RM. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin Biochem. 2016;49:302-315. [PMID: 26188920 DOI: 10.1016/j.clinbiochem.2015.07.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 58 |
Suh B, Yun JM, Park S, Shin DW, Lee TH, Yang HK, Ahn E, Lee H, Park JH, Cho B. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Cancer. 2015;121:3818-3825. [PMID: 26178294 DOI: 10.1002/cncr.29577] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 59 |
European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237-64. [PMID: 25911335 DOI: 10.1016/j.jhep.2015.04.006] [Cited by in Crossref: 1157] [Cited by in F6Publishing: 1197] [Article Influence: 144.6] [Reference Citation Analysis]
|
| 60 |
Vergara M, Bejarano G, Dalmau B, Gil M, Miquel M, Sanchez-Delgado J, Casas M, Puig J, Martinez-Bauer E, Dosal A, Lopez M, Moreno L, Valero O, Bella MR, Calvet X. Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2015;27:826-33. [PMID: 26043289 DOI: 10.1097/MEG.0000000000000346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 61 |
Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 62 |
Suh B, Park S, Shin DW, Yun JM, Yang HK, Yu SJ, Shin CI, Kim JS, Ahn E, Lee H, Park JH, Cho B. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology 2015;61:1261-8. [PMID: 25502481 DOI: 10.1002/hep.27654] [Cited by in Crossref: 70] [Cited by in F6Publishing: 78] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 63 |
Rodrigues-Pinto E, Cardoso H, Coelho R, Andrade P, Macedo G. Higher aspartate aminotransferase platelet ratio index predicts early significant liver-related events in hepatitis C genotype 1 chronic liver disease. Eur J Gastroenterol Hepatol 2015;27:361-2. [PMID: 25629576 DOI: 10.1097/MEG.0000000000000276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 64 |
Anderson JP, Horsburgh CR Jr, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR 3rd. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis 2015;2:ofv019. [PMID: 26034769 DOI: 10.1093/ofid/ofv019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 65 |
Izumi N, Tamaki N, Asahina Y, Kurosaki M. Fibrosis and fibrogenesis. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch05] [Reference Citation Analysis]
|
| 66 |
Castera L. Non-invasive diagnosis tests. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch06] [Reference Citation Analysis]
|
| 67 |
Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol 2015;2015:852968. [PMID: 26693356 DOI: 10.1155/2015/852968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 68 |
Berenguer J, Zamora FX, Aldámiz-echevarría T, Von Wichmann MA, Crespo M, López-aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-pellicer J, Esteban H, Bellón JM, González-garcía J, Miralles P, Cosín J, López J, Padilla B, Parras F, Carrero A, Aldamiz-echevarría T, Tejerina F, Gutiérrez I, Ramírez M, Carretero S, Bellón J, Berenguer J, Alvarez-pellicer J, Rodríguez E, Arribas J, Montes M, Bernardino I, Pascual J, Zamora F, Peña J, Arnalich F, Díaz M, González-garcía J, Bustinduy M, Iribarren J, Rodríguez-arrondo F, Von-wichmann M, Blanes M, Cuellar S, Lacruz J, Montero M, Salavert M, López-aldeguer J, Callau P, Miró J, Gatell J, Mallolas J, Ferrer A, Galindo M, Van den Eynde E, Pérez M, Ribera E, Crespo M, Vergas J, Téllez M, Casado J, Dronda F, Moreno A, Pérez-elías M, Sanfrutos M, Moreno S, Quereda C, Jou A, Tural C, Arranz A, Casas E, de Miguel J, Schroeder S, Sanz J, Condés E, Barros C, Sanz J, Santos I, Hernando A, Rodríguez V, Rubio R, Pulido F, Domingo P, Guardiola J, Ortiz L, Ortega E, Torres R, Cervero M, Jusdado J, Rodríguez-zapata M, Pérez G, Gaspar G, Barquilla E, Ramírez M, Moyano B, Aznar E, Esteban H; for the Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group. Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus. Clinical Infectious Diseases 2015;60:950-8. [DOI: 10.1093/cid/ciu939] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 69 |
Tamaki N, Kurosaki M, Matsuda S, Muraoka M, Yasui Y, Suzuki S, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J Gastroenterol 2014;49:1495-503. [PMID: 24337828 DOI: 10.1007/s00535-013-0914-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 70 |
Branchi F, Conti CB, Baccarin A, Lampertico P, Conte D, Fraquelli M. Non-invasive assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2014; 20(40): 14568-14580 [PMID: 25356021 DOI: 10.3748/wjg.v20.i40.14568] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 71 |
Motola DL, Caravan P, Chung RT, Fuchs BC. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep 2014;2:245-56. [PMID: 25396099 DOI: 10.1007/s40139-014-0061-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 72 |
Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 147] [Cited by in F6Publishing: 152] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 73 |
Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, Chermak F, Hubert IF, Merrouche W, Oberti F, de Lédinghen V, Calès P. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 2014;60:65-76. [PMID: 24519328 DOI: 10.1002/hep.27069] [Cited by in Crossref: 107] [Cited by in F6Publishing: 110] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 74 |
Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-Hubert I, Oberti F, Rousselet MC, Calès P. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C. Aliment Pharmacol Ther 2014;40:178-88. [PMID: 24889599 DOI: 10.1111/apt.12813] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 75 |
Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 76 |
Chinnaratha MA, Jeffrey GP, MacQuillan G, Rossi E, de Boer BW, Speers DJ, Adams LA. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2014;34:720-7. [PMID: 24034439 DOI: 10.1111/liv.12306] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 77 |
Pang JX, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, Shaheen AA, Coffin CS, Heitman SJ, Kaplan GG, Swain MG, Myers RP. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One 2014;9:e95776. [PMID: 24755824 DOI: 10.1371/journal.pone.0095776] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 78 |
Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V 3rd. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis 2014;58:1449-58. [PMID: 24569533 DOI: 10.1093/cid/ciu097] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 79 |
Procopet B, Berzigotti A. New Tools for the Noninvasive Assessment of Cirrhosis. Curr Hepatology Rep. [DOI: 10.1007/s11901-014-0210-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 80 |
Czaja AJ. Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther 2014;39:385-406. [PMID: 24387318 DOI: 10.1111/apt.12592] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 81 |
Saracino A, Bruno G, Scudeller L, Punzi G, Lagioia A, Ladisa N, Monno L, Angarano G. Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients? J Clin Virol. 2014;59:167-171. [PMID: 24461764 DOI: 10.1016/j.jcv.2013.12.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 82 |
References. Translational Biology in Medicine 2014. [DOI: 10.1016/b978-1-907568-42-8.50016-2] [Reference Citation Analysis]
|
| 83 |
Gemtessa TA, Chirch LM. Update on Hepatitis C Virus and HIV Coinfection. J Clin Transl Hepatol 2013;1:109-15. [PMID: 26355698 DOI: 10.14218/JCTH.2013.00018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 84 |
Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol 2013;10:666-75. [PMID: 24061203 DOI: 10.1038/nrgastro.2013.175] [Cited by in Crossref: 195] [Cited by in F6Publishing: 182] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 85 |
Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses 2013;29:1110-6. [PMID: 23601055 DOI: 10.1089/AID.2012.0348] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 86 |
Castera L. Natural History of Chronic HCV Infection and Non-Invasive Assessment of Hepatic Fibrosis. Viral Hepatitis 2013. [DOI: 10.1002/9781118637272.ch23] [Reference Citation Analysis]
|
| 87 |
Alfaleh FZ, Alswat K, Helmy A, Al-hamoudi W, El-sharkawy M, Omar M, Shalaby A, Bedewi MA, Hadad Q, Ali SM, Alfaleh A, Abdo AA. The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy. Liver Int 2013;33:871-83. [PMID: 23490034 DOI: 10.1111/liv.12127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 88 |
Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB; Canadian Co-infection Cohort Investigators. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. Clin Infect Dis 2013;57:663-70. [PMID: 23811492 DOI: 10.1093/cid/cit378] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 89 |
Peters L, Mocroft A, Soriano V, Rockstroh J, Rauch A, Karlsson A, Knysz B, Pradier C, Zilmer K, Lundgren JD. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients. PLoS One. 2013;8:e64283. [PMID: 23724041 DOI: 10.1371/journal.pone.0064283] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 90 |
Cassol E, Misra V, Holman A, Kamat A, Morgello S, Gabuzda D. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infect Dis 2013;13:203. [PMID: 23641933 DOI: 10.1186/1471-2334-13-203] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 91 |
Fuster D, Tsui JI, Cheng DM, Quinn EK, Bridden C, Nunes D, Libman H, Saitz R, Samet JH. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res. 2013;37:1527-1535. [PMID: 23647488 DOI: 10.1111/acer.12129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 92 |
de Lédinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, Le Bail B, Merrouche W, Bernard PH. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 2013;37:979-88. [PMID: 23557139 DOI: 10.1111/apt.12307] [Cited by in Crossref: 80] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 93 |
Fernández-Montero JV, Barreiro P, Vispo E, Labarga P, Sánchez-Parra C, Soriano V. Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy. AIDS 2013;27:1129-34. [PMID: 23276803 DOI: 10.1097/QAD.0b013e32835e063f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 94 |
Price J, Thio C. Reply to Post and Sabin. Journal of Infectious Diseases 2013;207:368-369. [DOI: 10.1093/infdis/jis665] [Reference Citation Analysis]
|
| 95 |
Tamaki N, Kurosaki M, Tanaka K, Suzuki Y, Hoshioka Y, Kato T, Yasui Y, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Asahina Y, Izumi N. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C. J Viral Hepat 2013;20:72-6. [PMID: 23231087 DOI: 10.1111/j.1365-2893.2012.01635.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 96 |
Holmes JA, Thompson AJ, Adams LA. Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C. Curr Hepatitis Rep 2012;11:231-242. [DOI: 10.1007/s11901-012-0148-0] [Reference Citation Analysis]
|
| 97 |
Muga R, Sanvisens A, Fuster D, Tor J, Martínez E, Pérez-Hoyos S, Muñoz A. Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One 2012;7:e46810. [PMID: 23056462 DOI: 10.1371/journal.pone.0046810] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 98 |
Wu WC, Chiou YY, Hung HH, Kao WY, Chou YH, Su CW, Wu JC, Huo TI, Huang YH, Lee KC, Lin HC, Lee SD. Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. J Clin Gastroenterol 2012;46:789-95. [PMID: 22941428 DOI: 10.1097/MCG.0b013e31825ceeb5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 99 |
Muhi A, Ichikawa T, Motosugi U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T. Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int 2013;7:662-8. [PMID: 26201799 DOI: 10.1007/s12072-012-9383-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 100 |
Ma C, Xie G, Zhang W, Liang M, Liu B, Xiang H. Label-free sandwich type of immunosensor for hepatitis C virus core antigen based on the use of gold nanoparticles on a nanostructured metal oxide surface. Microchim Acta 2012;178:331-40. [DOI: 10.1007/s00604-012-0842-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 101 |
Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, Choi JY, Han KH, Sung HT, Hong SH. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem. 2012;45:1075-1080. [PMID: 22579966 DOI: 10.1016/j.clinbiochem.2012.04.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 102 |
Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293-1302.e4. [PMID: 22537436 DOI: 10.1053/j.gastro.2012.02.017] [Cited by in Crossref: 438] [Cited by in F6Publishing: 461] [Article Influence: 39.8] [Reference Citation Analysis]
|
| 103 |
Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012;26:599-607. [PMID: 22156972 DOI: 10.1097/QAD.0b013e32834fa121] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 104 |
Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, Dore G, Puoti M, Tedaldi E, Clotet B, Kupfer B, Lundgren JD, Klein MB; SMART Study Group. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir Ther 2011;16:667-75. [PMID: 21817188 DOI: 10.3851/IMP1815] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 105 |
Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDS 2012;26:73-80. [PMID: 22239101 DOI: 10.1089/apc.2011.0191] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 106 |
Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012;205:1005-13. [PMID: 22291196 DOI: 10.1093/infdis/jir885] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 107 |
Smith JO, Sterling RK. Noninvasive Markers of Liver Injury and Fibrosis. HIV and Liver Disease 2012. [DOI: 10.1007/978-1-4419-1712-6_5] [Reference Citation Analysis]
|
| 108 |
Crespo G, Martinez SM, Forns X. Assessing the Progression of Chronic HCV to Cirrhosis. Chronic Hepatitis C Virus 2012. [DOI: 10.1007/978-1-4614-1192-5_3] [Reference Citation Analysis]
|
| 109 |
Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, Bohjanen PR, Novak RM, Neaton JD, Sereti I. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis. 2011;203:1637-1646. [PMID: 21592994 DOI: 10.1093/infdis/jir134] [Cited by in Crossref: 221] [Cited by in F6Publishing: 237] [Article Influence: 18.4] [Reference Citation Analysis]
|
| 110 |
Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis 2011;203:1807-14. [PMID: 21606539 DOI: 10.1093/infdis/jir192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 111 |
Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-9, 1979.e1-3. [PMID: 21376047 DOI: 10.1053/j.gastro.2011.02.058] [Cited by in Crossref: 291] [Cited by in F6Publishing: 305] [Article Influence: 24.3] [Reference Citation Analysis]
|
| 112 |
Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep 2011;8:12-22. [PMID: 21221855 DOI: 10.1007/s11904-010-0071-3] [Cited by in Crossref: 155] [Cited by in F6Publishing: 144] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 113 |
Clark PJ, Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol 2011;27:210-6. [PMID: 21248634 DOI: 10.1097/MOG.0b013e328343e9a3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Adams LA. Biomarkers of liver fibrosis. J Gastroenterol Hepatol 2011;26:802-9. [PMID: 21198831 DOI: 10.1111/j.1440-1746.2010.06612.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 115 |
Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 2011;25:291-303. [PMID: 21497746 DOI: 10.1016/j.bpg.2011.02.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 116 |
Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011;53:325-35. [PMID: 21254180 DOI: 10.1002/hep.24013] [Cited by in Crossref: 304] [Cited by in F6Publishing: 317] [Article Influence: 25.3] [Reference Citation Analysis]
|
| 117 |
Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol. 2010;40:2493-2505. [PMID: 20623550 DOI: 10.1002/eji.201040340] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 118 |
Peters L, Rockstroh JK. Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?: . Current Opinion in HIV and AIDS 2010;5:517-23. [DOI: 10.1097/coh.0b013e32833e3ee6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 119 |
Vali B, Tohn R, Cohen MJ, Sakhdari A, Sheth PM, Yue FY, Wong D, Kovacs C, Kaul R, Ostrowski MA. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses. J Virol 2011;85:254-63. [PMID: 20980521 DOI: 10.1128/JVI.01743-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 120 |
Hung HH, Su CW, Lai CR, Chau GY, Chan CC, Huang YH, Huo TI, Lee PC, Kao WY, Lee SD. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol Int. 2010;4:691-699. [PMID: 21286339 DOI: 10.1007/s12072-010-9213-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 121 |
Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425-36. [PMID: 20585339 DOI: 10.1038/nrgastro.2010.97] [Cited by in Crossref: 418] [Cited by in F6Publishing: 414] [Article Influence: 32.2] [Reference Citation Analysis]
|
